Cargando…

Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications

Hepatocellular carcinoma (HCC) is the fifth most common cancer and is the second leading cause of cancer death. Since the diagnosis of HCC is difficult, in many cases patients with HCC are diagnosed advanced stage of development. Hepatocyte growth factor (HGF)/c-mesenchymal-epithelial transition rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Vilas, Javier A, Medina, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127652/ https://www.ncbi.nlm.nih.gov/pubmed/30197476 http://dx.doi.org/10.3748/wjg.v24.i33.3695

Ejemplares similares

Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells
por: García-Vilas, Javier A., et al.
Publicado: (2015)

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017)

Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases
por: Whang, Young Mi, et al.
Publicado: (2019)

Targeting the HGF-cMET Axis in Hepatocellular Carcinoma
por: Venepalli, Neeta K., et al.
Publicado: (2013)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Hepatocyte Growth Factor/c-Met Signaling in Head and Neck Cancer and Implications for Treatment
por: Rothenberger, Natalie J., et al.
Publicado: (2017)

The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
por: Boissinot, Marjorie, et al.
Publicado: (2014)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Elevated hepatocyte growth factor expression as an autocrine c‐Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells
por: Firtina Karagonlar, Zeynep, et al.
Publicado: (2016)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
por: Alvarez-Perez, Juan Carlos, et al.
Publicado: (2014)

Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
por: Bouattour, Mohamed, et al.
Publicado: (2018)

MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET
por: SHENG, XIU-JIE, et al.
Publicado: (2014)

The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches
por: Hu, Chi-Tan, et al.
Publicado: (2017)

The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators
por: Moebius, Hans J., et al.
Publicado: (2023)

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
por: Verdugo, Elena, et al.
Publicado: (2022)

MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas
por: Schmitz, Katja, et al.
Publicado: (2015)

Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
por: Taniguchi, Hirokazu, et al.
Publicado: (2017)

Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros
Publicado: (1995)

The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment
por: Parikh, Rahul A, et al.
Publicado: (2014)

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors
por: Smyth, Elizabeth C, et al.
Publicado: (2014)

Editorial of Special Issue “New Aspects of the Hepatocyte Growth Factor/c-Met System”
por: Ricci, Giulia
Publicado: (2015)

Therapeutic Management of Advanced Hepatocellular Carcinoma: An Updated Review
por: Falette Puisieux, Manon, et al.
Publicado: (2022)

Hepatocyte ploidy in cats with and without hepatocellular carcinoma
por: Post, Jacqueline, et al.
Publicado: (2021)

Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain
Publicado: (1994)

A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met
por: Basilico, Cristina, et al.
Publicado: (2008)

Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?
por: Wang, Xiangdong, et al.
Publicado: (2010)

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression
por: NOGUCHI, EIICHIRO, et al.
Publicado: (2015)

Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma
por: Johnson, Jennifer, et al.
Publicado: (2015)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
por: Lee, Joycelyn J. X., et al.
Publicado: (2015)

A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
por: Luo, Teng, et al.
Publicado: (2019)

Disruption of Hepatocyte Growth Factor/c-Met Signaling Enhances Pancreatic β-Cell Death and Accelerates the Onset of Diabetes
por: Mellado-Gil, Jose, et al.
Publicado: (2011)

Notch–Sox9 Axis Mediates Hepatocyte Dedifferentiation in Kras(G12V)-Induced Zebrafish Hepatocellular Carcinoma
por: Sun, Junhui, et al.
Publicado: (2022)

Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
por: Cicchini, Carla, et al.
Publicado: (2015)

Targeting insulin-like growth factor axis in hepatocellular carcinoma
por: Wu, Jennifer, et al.
Publicado: (2011)

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients
por: Felix, A S, et al.
Publicado: (2012)

Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells
por: Tate, Amanda, et al.
Publicado: (2006)

A Hepatocyte Growth Factor Receptor (Met)–Insulin Receptor hybrid governs hepatic glucose metabolism
por: Fafalios, Arlee, et al.
Publicado: (2011)

Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
por: Buchanan, Ian M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jajcprhihuk31b2bq52p70p9oh